A low vitamin D status is associated with an increased risk of various cancers, such as of
colon, breast, prostate and hematological cells. The biologically most active vitamin D …

Vitamin D testing and treatment is a subject of controversial scientific discussions, and it is
challenging to navigate through the expanding vitamin D literature with heterogeneous and …

The genomic actions of the vitamin D are mediated via its biologically most potent metabolite
1α, 25‐dihydroxyvitamin D3 (1, 25 (OH) 2D3) and the transcription factor vitamin D receptor …

Vitamin D plays an important role in calcium homeostasis and bone metabolism, with the
capacity to modulate innate and adaptive immune function, cardiovascular function, and …

Recent research activities have provided new insights in vitamin D metabolism in various
conditions. Furthermore, substantial progress has been made in the analysis of vitamin D …

Renewing interest in the study of intermediate metabolism and cellular bioenergetics is
brought on by the global increase in the prevalence of metabolic illnesses. Understanding of …

For at least 1.2 billion years, eukaryotes have been able to synthesize sterols and, therefore,
can produce vitamin D when exposed to UV-B. Vitamin D endocrinology was established …

Uncontrolled overgrowth of cells, such as in cancer, is an unavoidable risk in life that affects
nearly every second individual in industrialized countries. However, in part this risk can be …

Nutrigenomics attempts to characterize and integrate the relation between dietary molecules
and gene expression on a genome-wide level. One of the biologically active nutritional …

Vitamin D 3 is produced non-enzymatically when the cholesterol precursor 7-
dehydrocholesterol is exposed to UV-B, ie, evolutionary the first function of the molecule was …